| 发明名称 |
Notch pathway signaling inhibitor compound |
| 摘要 |
The present invention provides a compound, or a pharmaceutically acceptable salt or hydrate, and a pharmaceutical composition containing said compound, or a pharmaceutically acceptable salt or hydrate, useful as a Notch pathway signaling inhibitor for the treatment of cancer |
| 申请公布号 |
AU2012287251(A1) |
申请公布日期 |
2014.01.30 |
| 申请号 |
AU20120287251 |
申请日期 |
2012.07.18 |
| 申请人 |
ELI LILLY AND COMPANY |
发明人 |
HIPSKIND, PHILIP ARTHUR;STEPHENSON, GREGORY ALAN |
| 分类号 |
C07K5/06;A61K38/05;A61P35/00;A61P35/02;C07D401/04 |
主分类号 |
C07K5/06 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
